-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Clinically, the use of central venous access devices or peripheral arterial catheters is high, and the risk of catheter-related bloodstream infection (CRBSI) in patients caused by invasive devices increases.
infection
Recently, researchers investigated the effectiveness and cost-effectiveness of replacing the access device or catheter every 4 days on the prevention of CRBSI compared with the standard 7-day use time limit .
Recently, researchers investigated the effectiveness and cost-effectiveness of replacing the access device or catheter every 4 days on the prevention of CRBSI compared with the standard 7-day use time limit .
The study was carried out in 10 Australian hospitals and was a randomized, controlled, non-inferior study.
child
2944 patients participated in the study, of which 1463 were in the 7-day replacement group, 1481 were in the 4-day replacement group, and the data of 2941 patients were included in the endpoint analysis.
In the central venous access device group, 20 out of 1124 patients (1.
The study believes that for patients who need to receive central venous access devices or peripheral arterial catheter interventions, shortening the equipment replacement time to 4 days cannot reduce the risk of catheter-related bloodstream infections.
For patients who need to receive central venous access device or peripheral arterial catheter intervention, shortening the equipment replacement time to 4 days cannot reduce the risk of catheter-related bloodstream infection.
Original source:
Prof Claire M Rickard et al .
.
Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)–non-inferiority (peripheral arterial catheter) trial.
Leave a message here
